StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

Equities researchers at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued on Tuesday. The firm set a “hold” rating on the stock.

ObsEva Stock Down 100.0 %

ObsEva has a fifty-two week low of $0.08 and a fifty-two week high of $2.14. The stock has a market cap of $7.94 million, a PE ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.